MEDI-6469 is under investigation in clinical trial NCT02205333 (A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies).
Synonyms: MEDI-6469
This is just here as a test because I lose it